Tweenvest Stocks

Whitehawk Therapeutics, Inc. (NasdaqCM: WHWK)

Health Care · Biotechnology · US

$3.52

-4.86% today · +72.5% 1Y

Whitehawk Therapeutics, Inc. (NasdaqCM: WHWK) operates in the Biotechnology industry within the Health Care sector. The company is valued at $200.67M and employs 32 people.

Over the last twelve months the share price has gained 72.5%, trading between 1.87 and 5.50.

Tweenvest scores Whitehawk Therapeutics, Inc. across four factors: quality 35/100, value 57/100, growth 0/100. Its strongest factor is value.

WHWK price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$200.67M
Revenue (TTM)
$0.00
P/E
—
EPS
-1.10
Dividend yield
—
Beta (5Y)
0.91
52-week high
$5.50
52-week low
$1.87
Avg volume (3M)
—
Shares outstanding
57.01M
Employees
32
Next earnings
—

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

ISIN
US00032Q1040
Founded
2007
Listed since
Aug 1, 2017
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Compugen Ltd.NasdaqCM: CGEN$201.76M$2.11-0.94%
Eledon Pharmaceuticals, Inc.NasdaqCM: ELDN$201.73M$2.48-0.40%
Biomm S.A.BOVESPA: BIOM3$201.65MR$7.34+13.80%
Cue Biopharma, Inc.NasdaqCM: CUE$200.93M$27.30-1.30%
S.Biomedics Co., Ltd.KOSDAQ: A304360$200.37M₩21,750.00+4.07%
Alpha Cognition Inc.NasdaqCM: ACOG$196.87M$9.04-0.66%
Thor Medical ASAOB: TRMED$196.75MNkr4.46-1.00%
IntoCell, Inc.KOSDAQ: A287840$193.53M₩17,320.00-4.04%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.